Antibodies from COVID-19 survivors could be used to treat patients
2 responses | 0 likes
Started by metmike - March 20, 2020, 2:24 p.m.

 Antibodies from COVID-19 survivors could be used to treat patients, protect those at risk


Infusions of antibody-laden blood have been used with reported success in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic

                                      Johns Hopkins University                                   

                                                                                                                                                                                                                      Image of virus and cells                        



With a vaccine for COVID-19 still a long way from being realized, Johns Hopkins immunologist Arturo Casadevall is working to revive a century-old blood-derived treatment for use in the United States in hopes of slowing the spread of the disease.

With the right pieces in place, the treatment could be set up at Johns Hopkins University in Baltimore within a matter of weeks, Casadevall says.

The technique uses antibodies from the blood plasma or serum of people who have recovered from COVID-19 infection to boost the immunity of newly infected patients and those at risk of contracting the disease. These antibodies contained in the blood's serum have the ability to bind to and neutralize SARS-CoV-2, the virus that causes COVID-19. Casadevall—a Bloomberg Distinguished Professor of molecular microbiology and immunology and infectious diseases at the Johns Hopkins Bloomberg School of Public Health and School of Medicine—published a paper on the proposal today in The Journal of Clinical Investigation.

By metmike - March 20, 2020, 2:26 p.m.
Like Reply

Here's the study:

The convalescent sera option for containing COVID-19

By metmike - March 20, 2020, 2:27 p.m.
Like Reply

Wall Street Journal: Hill School Doctor’s Approach to Measles in 1934 Has Lessons for Coronavirus

Gallagher feared a wider outbreak, so he extracted serum from the blood of the initial patient he believed contained antibodies and infused it into the bodies of 62 other boys.

Only three of them contracted the disease and all of the cases were mild. The prompt reaction earned Gallagher a place in public health history.

Meanwhile, his approach might help contain a coronavirus pandemic. Recovering patients could donate their blood, which would be tested by doctors for the antibodies that kill the coronavirus.

This serum could be then given to those who are at high risk of infection.